Pharmacologic treatment of impotence.
A discussion of the anatomy, neurophysiology, endocrinology, and organ pharmacology pertinent to erectile function is presented, highlighting recent innovations in the pharmacologic treatment of impotence. Both oral and intracorporal pharmacologic agents that affect erectile dysfunction are discussed.
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage; D000728:Androgens / Q000502:physiology; D007172:Erectile Dysfunction / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D007267:Injections; D008297:Male; D018377:Neurotransmitter Agents / Q000502:physiology; D010410:Penile Erection / Q000187:drug effects; D010413:Penis / Q000098:blood supply / Q000294:innervation; D011388:Prolactin / Q000502:physiology; D013739:Testosterone / Q000627:therapeutic use*; D015016:Yohimbine / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D000728:Androgens; D018377:Neurotransmitter Agents; D015016:Yohimbine; D013739:Testosterone; D011388:Prolactin